Optimizing Care for Patients With Dementia
1 other identifier
interventional
53
1 country
1
Brief Summary
Of the 1.4 million nursing home (NH) residents in long term care facilities, more than half have Alzheimer's disease or dementia. Due to changes in their familiar daily routines, difficulty expressing their thoughts or asking for what they need, and overstimulation (such as noise) or under stimulation (such as lack of activity), individuals with dementia often display disruptive behaviors like resisting help or continually repeating the same phrases. Medications are often prescribed to reduce agitation and aggressive behavior; however, these medications may not be effective and can have a negative impact on the individual. Therefore, families and other stakeholders strongly advocate the use of other types of approaches that focus on minimizing the cause of the behavior. Two facility-based methodologies include the transdisciplinary approach for integrated dementia care, which combines the expertise of all NH staff, who work together to build a common language and approach for each resident, and the multidisciplinary approach for problem-based dementia care, in which each staff member conducts individual assessments and makes discipline-specific recommendations. While prior research suggests that both of these facility-based approaches are useful, the circumstances under which each approach is most effective are not clear. This project will prospectively randomize 80 nursing homes to one of the two treatment arms to compare the effect of the transdisciplinary approach versus the multidisciplinary approach. This study will examine the difference between the two comparators with respect to facility rates of medications dispensed to residents with dementia, leading to enhanced quality of life for the resident. This project is important because it will address a key clinical dilemma NH staff face as they strive to optimize the use of alternative approaches to reduce disruptive behaviors in residents with dementia. Transforming the quality of dementia care in NHs and enhancing the quality of life of residents with dementia are high priorities for families and other advocates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable alzheimer-disease
Started Mar 2018
Longer than P75 for not_applicable alzheimer-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2018
CompletedFirst Posted
Study publicly available on registry
February 22, 2018
CompletedStudy Start
First participant enrolled
March 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 26, 2022
CompletedResults Posted
Study results publicly available
August 19, 2024
CompletedAugust 19, 2024
March 1, 2024
4.4 years
January 31, 2018
June 30, 2023
March 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Dispensing of Psychotropic Medications
Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 1-6 of Intervention.
6-month period (months 1-6)
Dispensing of Psychotropic Medications
Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 7-12 of Intervention.
12-month period (months 7-12)
Dispensing of Psychotropic Medications
Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 13-18 of Intervention.
18-month period (months 13-18)
Behavioral Symptoms
Percentage of nursing home residents with dementia who had behavioral symptoms over Months 1-6 of Intervention.
6-month period (months 1-6)
Behavioral Symptoms
Percentage of nursing home residents with dementia who had behavioral symptoms over Months 7-12 of Intervention.
12-month period (months 7-12)
Behavioral Symptoms
Percentage of nursing home residents with dementia who had behavioral symptoms over Months 13-18 of Intervention.
18-month period (months 13-18)
Wandering
Percentage of nursing home residents with dementia who had wandering over Months 1-6 of Intervention.
6-month period (months 1-6)
Wandering
Percentage of nursing home residents with dementia who had wandering over Months 7-12 of Intervention.
12-month period (months 7-12)
Wandering
Percentage of nursing home residents with dementia who had wandering over Months 13-18 of Intervention.
18-month period (months 13-18)
Rejection of Care
Percentage of nursing home residents with dementia who had rejection of care over Months 1-6 of Intervention.
6-month period (months 1-6)
Rejection of Care
Percentage of nursing home residents with dementia who had rejection of care over Months 7-12 of Intervention.
12-month period (months 7-12)
Rejection of Care
Percentage of nursing home residents with dementia who had rejection of care over Months 13-18 of Intervention.
18-month period (months 13-18)
Secondary Outcomes (12)
Unintended Weight Loss
6-month period (months 1-6)
Unintended Weight Loss
12-month period (months 7-12)
Unintended Weight Loss
18-month period (months 13-18)
Falls
6-month period (months 1-6)
Falls
12-month period (months 7-12)
- +7 more secondary outcomes
Study Arms (2)
transdisciplinary approach
ACTIVE COMPARATORThe transdisciplinary approach that is integrated across disciplines and provides core training for all providers, staff members, and stakeholders, using a common language to address care concerns and support continuity and sustainability
multidisciplinary approach
ACTIVE COMPARATORThe multidisciplinary approach that is problem-based and draws on the expertise of individual healthcare providers (e.g., occupational therapy) to address care concerns.
Interventions
This approach is integrated across disciplines and provides core training for all providers, staff members, and stakeholders, using a common language to address care concerns and support continuity and sustainability;
This is a problem-based approach that draws on the expertise of individual healthcare providers (e.g., occupational therapy) to address care concerns.
Eligibility Criteria
You may qualify if:
- Eligible nursing home facilities will
- lack any existing dementia program targeting reduction of off-label psychotropic medication use
- each serve \>60 long-term care residents with Alzheimer's or dementia
- meet Center for Medicare \& Medicaid Services' minimum requirements for NHs (e.g., meeting the mandated number of hours of staff training on dementia care, performing regularly scheduled resident assessments).
You may not qualify if:
- Facilities will be excluded if they have
- less than 60 long-stay residents
- an existing formal dementia care program in place
- an off-label psychotropic medication reduction program
- is located in a state that requires more than the Center for Medicare \& Medicaid Services' minimum for staff training requirements on the topic of dementia care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Related Publications (1)
Piersol CV, Martinez J, Chew F, Perry B, Leland NE. Understanding the Experiences of Family Caregivers of Nursing Home Residents With Dementia: A Grounded Theory Study. Gerontologist. 2024 Apr 1;64(4):gnad102. doi: 10.1093/geront/gnad102.
PMID: 37501632DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
We were only able to assess post-training outcomes for 6 months prior to COVID-19 and it is possible that nursing homes would have achieved different outcomes after this initial start-up period. Similarly, the comparative effectiveness of the care approaches in 12- and 18-month follow-up period were confounded by the effects of COVID-19. Finally, the use of antipsychotic medication outcome was collected with a 7-day look back period, which may have resulted in underreporting.
Results Point of Contact
- Title
- Natalie Leland
- Organization
- University of Pittsburgh
Study Officials
- PRINCIPAL INVESTIGATOR
Natalie E Leland, PhD
University of Pittsburgh
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors will be blinded to the treatment arm the facility is randomly assigned to.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 31, 2018
First Posted
February 22, 2018
Study Start
March 15, 2018
Primary Completion
July 26, 2022
Study Completion
July 26, 2022
Last Updated
August 19, 2024
Results First Posted
August 19, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share